All Professionals
Overview
Jiaxuan Wang is an associate in the Corporate Department of Paul Hastings and is based in the firm’s Beijing office. Her practice focuses on initial public offerings and transactions related to the Hong Kong capital market, as well as providing post-IPO compliance services.
Jiaxuan is admitted in New York. She is fluent in English and Mandarin Chinese.
Education
- Wuhan University, J.M. 2021
- Northwestern University, LL.M. 2020
- Renmin University of China, B.A., LL.B 2018
Representations
- Lianlian DigiTech Co., Ltd., a digital payment solution provider from China, on its HK$657 million global offering and IPO on the Main Board of the Hong Kong Stock Exchange.*
- ZJLD Group Inc, a leading baijiu company in China, on its HK$5.3 billion global offering and IPO on the Main Board of the Hong Kong Stock Exchange.*
- Morgan Stanley and CICC as joint sponsors and joint global coordinators, on the HK$1.49 billion global offering and IPO on the Main Board of the Hong Kong Stock Exchange of Yonghe Medical Group Co., Ltd., a leading medical group in China specializing in providing hair-related healthcare services.*
- Abbisko Cayman Limited, a clinical-stage biopharmaceutical company dedicated to the discovery and development of innovative and differentiated small molecule oncology therapies, on its HK$225 million global offering and IPO on the Main Board of the Hong Kong Stock Exchange.*
* Including projects worked on prior to joining Paul Hastings.